sebacic acid has been researched along with Atherogenesis in 1 studies
sebacic acid : An alpha,omega-dicarboxylic acid that is the 1,8-dicarboxy derivative of octane.
| Excerpt | Relevance | Reference |
|---|---|---|
| "D-Threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP), a glycosphingolipid synthesis inhibitor, holds promise for the treatment of atherosclerosis and cardiac hypertrophy but rapid in vivo clearance has severely hindered translation to the clinic." | 3.81 | Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor. ( Amuzie, C; Bedja, D; Bhattacharya, R; Chatterjee, S; Foss, CA; Mishra, S; Pomper, MG; Yarema, KJ, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mishra, S | 1 |
| Bedja, D | 1 |
| Amuzie, C | 1 |
| Foss, CA | 1 |
| Pomper, MG | 1 |
| Bhattacharya, R | 1 |
| Yarema, KJ | 1 |
| Chatterjee, S | 1 |
1 other study available for sebacic acid and Atherogenesis
| Article | Year |
|---|---|
Improved intervention of atherosclerosis and cardiac hypertrophy through biodegradable polymer-encapsulated delivery of glycosphingolipid inhibitor.
Topics: Animals; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Capsules; Cardiomegaly; Cholesterol, D | 2015 |